Gynecology/Obstetrics News

Women reported a small increase in the likelihood of greater total bleeding during a menstrual cycle after receiving the COVID-19 vaccine, according to an observational study published in BJOG.

On Wednesday, judges from the 5th U.S. Circuit Court of Appeals granted a stay of a federal court decision that would reverse FDA approval of the abortion drug mifepristone. That original decision is on hold during the appeals process.

Developing menopause at an earlier age and late initiation of hormone therapy were associated with increased vulnerability to Alzheimer’s disease, according to researchers.

On April 7, a U.S. District Court judge in Texas suspended FDA approval of the abortifacient mifepristone giving the government 7 days to appeal, and a second judge in Washington ruled not to restrict the drug in states allowing abortion.

High levels of lead and cadmium in dark chocolate can have adverse effects for pregnant women and their fetuses, according to experts.

The Healio Editors compiled a list of recent news from the Society of Gynecologic Oncology Annual Meeting held from March 25-28, 2023.

Mailing HPV self-sampling kits to women who are overdue for cervical cancer screening was cost-effective in increasing screening uptake compared with usual care, according to an economic evaluation published in JAMA Network Open.

Women with a history of infertility have an increased risk for CHD, but not stroke, according to a study published in the Journal of the American Heart Association.

Insurance status substantially mediated racial and ethnic inequities among women with advanced-stage cervical cancer, researchers reported in JAMA Network Open.

Covis Pharma Group has submitted a response to the presiding officer’s report on the FDA advisory committee hearing on the proposal to withdrawal approval for a preterm birth prevention drug, according to a press release.